Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 2Head & Neck 1Gynecologic 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 389Head and Neck Neoplasms 340Carcinoma, Non-Small-Cell Lung 230Melanoma 155Colorectal Neoplasms 152Breast Neoplasms 138Ovarian Neoplasms 125Neoplasms 103Stomach Neoplasms 101Carcinoma, Renal Cell 101Neoplasm Metastasis 94Pancreatic Neoplasms 93Lung Neoplasms 87Uterine Cervical Neoplasms 81Triple Negative Breast Neoplasms 75Esophageal Neoplasms 75Prostatic Neoplasms 70Urinary Bladder Neoplasms 69Thyroid Neoplasms 62Carcinoma, Squamous Cell 57Carcinoma, Hepatocellular 57Sarcoma 54Endometrial Neoplasms 54Carcinoma, Transitional Cell 54Small Cell Lung Carcinoma 50Salivary Gland Neoplasms 49Colonic Neoplasms 41Nasopharyngeal Carcinoma 38Mouth Neoplasms 37Kidney Neoplasms 34

Interventions

Oxaliplatin 1Nivolumab 1Leucovorin 1Fluorouracil 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Spinocerebellar Degenerations × Head & Neck × Clear all
NCT06544655 2026-04-17

A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

Bristol-Myers Squibb

Phase 1 Active not recruiting
213 enrolled
GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Spinocerebellar Degenerations, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡